Year: 2016
Type: review
Abstract: Aging is the most important risk factor for human neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases. Pathologically, these diseases are characterized by the deposition of specific protein aggregates in neurons and glia, representing the impairment of neuronal proteostasis. However, the mechanism by which aging affects the proteostasis system and promotes protein aggregation remains largely unknown. The short lifespan and ample genetic resources of Caenorhabditis elegans (C. elegans) have made this species a favorite model organism for aging research, and the development of proteinopathy models in this organism has helped us to understand how aging processes affect protein aggregation and neurodegeneration. Here, we review the recent literature on proteinopathies in C. elegans models and discuss the insights we have gained into the mechanisms of how aging processes are integrated into the pathogenesis of various neurodegenerative diseases. Studies on proteinopathy, abnormal protein aggregation in cells, may yield new therapies for aging and neurodegenerative diseases. Seung-Jae Lee and colleagues at Seoul National University College of Medicine in South Korea reviewed insights into proteinopathies gained using the worm Caenorhabditis elegans as a model for aging and neurodegeneration. This tiny creature has long been used to investigate biochemical mechanisms of aging that are believed to be relevant in many organisms, including ourselves. The authors discuss recent research into several specific molecular signaling pathways in the worm that may also be involved in human ageing and in age-related diseases such as Alzheimer's and Parkinson's. They conclude that studying proteinopathies in C. elegans could reveal targets for new drugs to prevent and treat neurodegenerative conditions in humans.
DOI: 10.1038/emm.2016.109
Authors: Dong-Kyu Kim, Tae Ho Kim, Seung-Jae Lee
Language: English
Subfield: Aging
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $4,490
Funder: National Research Foundation
OpenAlex ID: W2529741867
